lacosamide oral solution

Generic: lacosamide

Labeler: chartwell governmental & specialty rx, llc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name lacosamide oral solution
Generic Name lacosamide
Labeler chartwell governmental & specialty rx, llc.
Dosage Form SOLUTION
Routes
ORAL
Active Ingredients

lacosamide 10 mg/mL

Manufacturer
Chartwell Governmental & Specialty RX, LLC.

Identifiers & Regulatory

Product NDC 68999-885
Product ID 68999-885_4ba97913-d84d-a2c3-e063-6394a90a2363
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA215154
DEA Schedule cv
Listing Expiration 2027-12-31
Marketing Start 2024-05-15

Pharmacologic Class

Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 68999885
Hyphenated Format 68999-885

Supplemental Identifiers

RxCUI
993856
UNII
563KS2PQY5
NUI
N0000008486

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name lacosamide oral solution (source: ndc)
Generic Name lacosamide (source: ndc)
Application Number ANDA215154 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 10 mg/mL
source: ndc
Packaging
  • 2 TRAY in 1 BOX (68999-885-23) / 10 CUP in 1 TRAY / 10 mL in 1 CUP (68999-885-10)
  • 2 TRAY in 1 BOX (68999-885-24) / 10 CUP in 1 TRAY / 5 mL in 1 CUP (68999-885-05)
source: ndc

Packages (2)

Ingredients (1)

lacosamide (10 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4ba97913-d84d-a2c3-e063-6394a90a2363", "openfda": {"nui": ["N0000008486"], "unii": ["563KS2PQY5"], "rxcui": ["993856"], "spl_set_id": ["e265fd09-8149-4423-a317-5760d34b8e9b"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Chartwell Governmental & Specialty RX, LLC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 TRAY in 1 BOX (68999-885-23)  / 10 CUP in 1 TRAY / 10 mL in 1 CUP (68999-885-10)", "package_ndc": "68999-885-23", "marketing_start_date": "20260114"}, {"sample": false, "description": "2 TRAY in 1 BOX (68999-885-24)  / 10 CUP in 1 TRAY / 5 mL in 1 CUP (68999-885-05)", "package_ndc": "68999-885-24", "marketing_start_date": "20260114"}], "brand_name": "Lacosamide Oral Solution", "product_id": "68999-885_4ba97913-d84d-a2c3-e063-6394a90a2363", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "68999-885", "dea_schedule": "CV", "generic_name": "Lacosamide", "labeler_name": "Chartwell Governmental & Specialty RX, LLC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lacosamide Oral Solution", "active_ingredients": [{"name": "LACOSAMIDE", "strength": "10 mg/mL"}], "application_number": "ANDA215154", "marketing_category": "ANDA", "marketing_start_date": "20240515", "listing_expiration_date": "20271231"}